» Articles » PMID: 34792120

Perfluorooctanesulfonic Acid Modulates Barrier Function and Systemic T-cell Homeostasis During Intestinal Inflammation

Overview
Journal Dis Model Mech
Specialty General Medicine
Date 2021 Nov 18
PMID 34792120
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The intestinal epithelium is continuously exposed to deleterious environmental factors that might cause aberrant immune responses leading to inflammatory disorders. However, what environmental factors might contribute to disease are poorly understood. Here, to overcome the lack of in vivo models suitable for screening of environmental factors, we used zebrafish reporters of intestinal inflammation. Using zebrafish, we interrogated the immunomodulatory effects of polyfluoroalkyl substances, which have been positively associated with ulcerative colitis incidence. Exposure to perfluorooctanesulfonic acid (PFOS) during 2,4,6-trinitro-benzene sulfonic acid (TNBS)-induced inflammation enhanced the expression of proinflammatory cytokines as well as neutrophil recruitment to the intestine of zebrafish larvae, which was validated in the TNBS-induced colitis mouse model. Moreover, PFOS exposure in mice undergoing colitis resulted in neutrophil-dependent increased intestinal permeability and enhanced PFOS translocation into the circulation. This was associated with a neutrophil-dependent expansion of systemic CD4+ T cells. Thus, our results indicate that PFOS worsens inflammation-induced intestinal damage with disruption of T-cell homeostasis beyond the gut and provides a novel in vivo toolbox to screen for pollutants affecting intestinal homeostasis.

Citing Articles

Associations between per-and polyfluoroalkyl substances (PFAS) and county-level cancer incidence between 2016 and 2021 and incident cancer burden attributable to PFAS in drinking water in the United States.

Li S, Oliva P, Zhang L, Goodrich J, McConnell R, Conti D J Expo Sci Environ Epidemiol. 2025; .

PMID: 39789195 DOI: 10.1038/s41370-024-00742-2.


Emerging role of environmental pollutants in inflammatory bowel disease risk, outcomes and underlying mechanisms.

Estevinho M, Midya V, Cohen-Mekelburg S, Allin K, Fumery M, Pinho S Gut. 2024; 74(3):477-486.

PMID: 39179372 PMC: 11802320. DOI: 10.1136/gutjnl-2024-332523.


The role of perfluorooctane sulfonic acid (PFOS) exposure in inflammation of intestinal tissues and intestinal carcinogenesis.

Durham J, Tessmann J, Deng P, Hennig B, Zaytseva Y Front Toxicol. 2023; 5:1244457.

PMID: 37662676 PMC: 10469509. DOI: 10.3389/ftox.2023.1244457.


Review of the zebrafish as a model to investigate per- and polyfluoroalkyl substance toxicity.

Rericha Y, Simonich M, Truong L, Tanguay R Toxicol Sci. 2023; 194(2):138-152.

PMID: 37220906 PMC: 10375317. DOI: 10.1093/toxsci/kfad051.


Perfluorooctane Sulfonic Acid Disrupts Protective Tight Junction Proteins via Protein Kinase D in Airway Epithelial Cells.

Lucas J, Wang Q, Rahman I Toxicol Sci. 2022; 190(2):215-226.

PMID: 36106993 PMC: 9960012. DOI: 10.1093/toxsci/kfac096.


References
1.
Xu Y, Fletcher T, Pineda D, Lindh C, Nilsson C, Glynn A . Serum Half-Lives for Short- and Long-Chain Perfluoroalkyl Acids after Ceasing Exposure from Drinking Water Contaminated by Firefighting Foam. Environ Health Perspect. 2020; 128(7):77004. PMC: 7351026. DOI: 10.1289/EHP6785. View

2.
Ye L, Mueller O, Bagwell J, Bagnat M, Liddle R, Rawls J . High fat diet induces microbiota-dependent silencing of enteroendocrine cells. Elife. 2019; 8. PMC: 6937151. DOI: 10.7554/eLife.48479. View

3.
Ulhaq M, Carlsson G, Orn S, Norrgren L . Comparison of developmental toxicity of seven perfluoroalkyl acids to zebrafish embryos. Environ Toxicol Pharmacol. 2013; 36(2):423-426. DOI: 10.1016/j.etap.2013.05.004. View

4.
Ananthakrishnan A . Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015; 12(4):205-17. DOI: 10.1038/nrgastro.2015.34. View

5.
Ananthakrishnan A, Bernstein C, Iliopoulos D, MacPherson A, Neurath M, Raja Ali R . Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastroenterol Hepatol. 2017; 15(1):39-49. DOI: 10.1038/nrgastro.2017.136. View